Previous close | 11.22 |
Open | 11.19 |
Bid | 11.15 x 2200 |
Ask | 11.17 x 1600 |
Day's range | 11.10 - 11.49 |
52-week range | 8.74 - 13.62 |
Volume | |
Avg. volume | 9,172,582 |
Market cap | 13.288B |
Beta (5Y monthly) | 1.13 |
PE ratio (TTM) | 223.20 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 0.48 (4.06%) |
Ex-dividend date | 08 Mar 2024 |
1y target est | N/A |
Reports Total Revenues of $3.66 Billion; U.S. GAAP Net Earnings of $113.9 Million; Adjusted EBITDA of $1.19 Billion; U.S. GAAP EPS of $0.09; Adjusted EPS of $0.67; U.S. GAAP Net Cash Provided by Operating Activities of $615 Million; and Free Cash Flow of $565 Million for the First Quarter
Viatris Inc. (NASDAQ: VTRS), a global healthcare company, today announced the company will participate in the BofA Securities 2024 Health Care Conference at the Encore Hotel in Las Vegas, Nevada on Tuesday, May 14, 2024. Chief Financial Officer Doretta Mistras and Chief R&D Officer Philippe Martin will represent the company in a fireside chat scheduled at 10 a.m. PT / 1 p.m. ET.
Viatris Inc. (NASDAQ: VTRS), a global healthcare company, recently launched Unmind as part of its global wellbeing program, Elevate. Unmind is a leading provider of workplace mental health solutions designed by psychologists to help individuals understand and be proactive with their mental health and lead healthier, happier lives.